tiprankstipranks
Advertisement
Advertisement
WALD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsWALD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Waldencast: Regulatory Overhang Cleared, Brand Growth Prospects Support Buy Rating and Unchanged $2 Price Target
Premium
Ratings
Waldencast: Regulatory Overhang Cleared, Brand Growth Prospects Support Buy Rating and Unchanged $2 Price Target
2M ago
Waldencast Clears SEC Probe Over Obagi-Related Accounting Issues
Premium
Company Announcements
Waldencast Clears SEC Probe Over Obagi-Related Accounting Issues
2M ago
Waldencast price target lowered to $2 from $4 at Canaccord
PremiumThe FlyWaldencast price target lowered to $2 from $4 at Canaccord
4M ago
Waldencast price target lowered to $2 from $4 at Canaccord
Premium
The Fly
Waldencast price target lowered to $2 from $4 at Canaccord
4M ago
Waldencast Posts Flat 2025 Results as Obagi Surges, Launches Strategic Review and Deleveraging Drive
Premium
Company Announcements
Waldencast Posts Flat 2025 Results as Obagi Surges, Launches Strategic Review and Deleveraging Drive
4M ago
Obagi Medical, DermFx collaborate for ALOHA program
PremiumThe FlyObagi Medical, DermFx collaborate for ALOHA program
5M ago
Obagi Medical, Moxie collaborate for ALOHA program
Premium
The Fly
Obagi Medical, Moxie collaborate for ALOHA program
5M ago
Obagi Medical, VIO Med Spa announce collaboration in ALOHA program
Premium
The Fly
Obagi Medical, VIO Med Spa announce collaboration in ALOHA program
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100